What You Should Know:
– Lunit, a provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader in innovative and comprehensive laboratory services, today announced a strategic collaborative initiative. The partnership…
Continue Reading
What You Should Know:
– Lunit, a provider of AI for cancer diagnostics and therapeutics announced a strategic collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions globally.
– The partnership, coupled with Lunit’s…
Continue Reading
Population-wide cancer screening programs in Germany have tapped support from South Korean medical imaging AI providers.KOSDAQ-listed Lunit recently signed a five-year partnership with private radiology network Starvision Service to deploy several medical imaging AI…
Continue Reading
An AI-powered lung cancer screening analysis software by South Korean company Coreline Soft has been added to the medical AI platform of global pharmaceutical firm Bayer. Its flagship product, AVIEW LCS, is now among the selections of…
Continue Reading
What You Should Know:
– SimonMed Imaging, one of the largest and most advanced outpatient medical imaging providers in the United States, announced a significant partnership with Lunit, a global leader in AI-driven cancer diagnostics…
Continue Reading
What You Should Know:
– Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced a collaboration with the National Cancer Institute (NCI), part of the U.S. National Institutes of Health (NIH).
–…
Continue Reading
Study Confirms AI Boosts Cancer Detection Rates
Lunit’s groundbreaking research published in Nature Communications has validated the effectiveness of AI-powered mammography screening in real-world settings. This first-of-its-kind large-scale, multicenter prospective study demonstrated that AI assistance…
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
Back-to-back news over the past few years since the recent pandemic reported on the aggressive global expansion of South Korean companies in the medical imaging AI space. From securing regulatory approvals to closing national and…
Continue Reading
“AI in diagnostics is where the future is going to be. And I think our kids will look back on healthcare now and think, ‘Oh my gosh, radiologists used to just read those images…
Continue Reading
